4//SEC Filing
Quisel John D 4
Accession 0000950170-25-095338
CIK 0001816736other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 4:48 PM ET
Size
10.7 KB
Accession
0000950170-25-095338
Insider Transaction Report
Form 4
Quisel John D
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-07-09$9.86/sh+34,800$343,128→ 196,628 total - Sale
Common Stock
2025-07-09$55.23/sh−31,207$1,723,600→ 165,421 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-07-09−34,800→ 115,375 totalExercise: $9.86Exp: 2031-09-13→ Common Stock (34,800 underlying) - Sale
Common Stock
2025-07-09$56.20/sh−3,593$201,925→ 161,828 total
Footnotes (4)
- [F1]The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.33, inclusive.
- [F4]The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Disc Medicine, Inc.
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001586788
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 4:48 PM ET
- Size
- 10.7 KB